My Cancer Genome: Genetically Informed Cancer Medicine

  • Home
  • DIRECT
  • About Us
  • Acute Lymphoblastic Leukemia
  • Acute Myeloid Leukemia
  • Anaplastic Large Cell Lymphoma
  • Basal Cell Carcinoma
  • Bladder Cancer
  • Breast Cancer
  • Chronic Lymphocytic Leukemia
  • Chronic Myeloid Leukemia
  • Colorectal Cancer
  • GIST
  • Gastric Cancer
  • Glioma
  • Inflammatory Myofibroblastic Tumor
  • Lung Cancer
  • Medulloblastoma
  • Melanoma
  • Myelodysplastic Syndromes
  • Neuroblastoma
  • Ovarian Cancer
  • Prostate Cancer
  • Rhabdomyosarcoma
  • Thymic Carcinoma
  • Thyroid Cancer
  • Molecular Medicine
    • Anticancer Agents
    • Circulating Tumor DNA
    • Detecting Gene Alterations in Cancers
    • Immunotherapy in Cancer
    • Overview of Targeted Therapies for Cancer
    • Pathways
    • Types of Molecular Tumor Testing
  • Take Our Survey
  • Glossary
  • News
  • Our Team
  • Acknowledgements

Cellular Architecture and Microenvironment

The intra- and intercellular architecture of tumor cells plays an important role in cellular processes. The tumor cell has polarity defined by the presence of specific cytoskeletal features. The coordinated function of the cytoskeletal and architectural features of the cell allow regulation of processes within and across the cell. For example, nutrients and chemical mediators can be passed through an individual cell from the apical membrane to the basolateral membrane or passed in between the cell via cell-cell junctions at the basolateral membrane.

arch color

Figure 1. Simplified schematic of a polarized epithelial cell showing the apical membrane at the top of the cell and the basolateral membrane at the sides of the cell. Click here to open a larger version of this image in a new window.

Upstream Pathways

  • Receptor tyrosine kinase/growth factor signaling

Downstream Pathways

  • MAP kinase signaling

Therapies That Target This Pathway

  • PTK2 (FAK)inhibitors
  • SRC inhibitors

Genes Involved in the Pathway

  • PTK2
  • SRC

Last Updated: May 24, 2016

Disclaimer: The information presented at MyCancerGenome.org is compiled from sources believed to be reliable. Extensive efforts have been made to make this information as accurate and as up-to-date as possible. However, the accuracy and completeness of this information cannot be guaranteed. Despite our best efforts, this information may contain typographical errors and omissions. The contents are to be used only as a guide, and health care providers should employ sound clinical judgment in interpreting this information for individual patient care.

  • MCG Home |
  • About Us |
  • Acknowledgments |
  • Give |
  • Site Map |
  • Legal |
  • APIs and Licensing
My Cancer Genome is managed by the Vanderbilt-Ingram Cancer Center   Copyright © 2010 - 2017 MY CANCER GENOME